Trade Summary

3 days ago, Alvino Mark, serving as Dir at Abeona Therapeutics Inc. (ABEO), sold 6,500 shares at $5.46 per share, for a total transaction value of $35,463.00. Following this transaction, Alvino Mark now holds 77,565 shares of ABEO.

This sale represents a 8.00% decrease in Alvino Mark's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 22, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 22, 2026 at 5:24 PM ET, meaning the disclosure happened on the same day as the trade.

Abeona Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.